Publications by authors named "Angeline Shen"

Claim this Profile
I
Increased Prevalence of Germline Pathogenic CHEK2 Variants in Individuals With Pituitary Adenomas.
Sunita M C De Sousa, Ann McCormack, Andreas Orsmond, Angeline Shen, Christopher J Yates

J Clin Endocrinol Metab· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of semaglutide and dulaglutide shortages on Pharmaceutical Benefits Scheme prescriptions supplied for type 2 diabetes treatment.
Sachin Phakey, Angeline Shen

Aust J Gen Pract· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
variants in patients with thyrotrophinomas, cyclical Cushing's disease and prolactinomas.
Sunita M C De Sousa, Angeline Shen, Christopher J Yates, Roderick Clifton-Bligh, Stephen Santoreneos

Front Endocrinol (Lausanne)· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Genomic Landscape of Sporadic Prolactinomas.
Sunita M C De Sousa, Paul P S Wang, Stephen Santoreneos, Angeline Shen, Christopher J Yates

Endocr Pathol· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Insights into pituitary tumorigenesis: from Sanger sequencing to next-generation sequencing and beyond.
Angeline Jia Jia Shen, James King, Hamish Scott, Peter Colman, Christopher J Yates

Expert Rev Endocrinol Metab· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Histological and Extended Clinical Outcomes After ABO-Incompatible Renal Transplantation Without Splenectomy or Rituximab.
Kevin V Chow, Shaun M Flint, Angeline Shen, Anthony Landgren, Moira Finlay

Transplantation· June 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis